Egalet Announces Update On Clinical Development Plan For Abuse-Deterrent Morphine Egalet-001
September 23, 2014 at 16:00 PM EDT
Egalet Corporation (Nasdaq: EGLT) (Egalet) today announced an update to the clinical development plan for Egalet-001, an ...